![Insights from 2023 ASCO® Annual Meeting](http://media.vumedi.com/thumbs/channel_logo/2023/5/a2df459d-f523-49c6-86db-fbc880f4b695.png.200x0_q85.png)
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Insights: "Results of MOLTO, a Multicenter, Open Label, Ph2 Clinical Trial Evaluating Venetoclax, Atezolizumab, + Obinutuzumab in Richter Syndrome"
By
Insights from 2023 ASCO® Annual Meeting
FEATURING
Anna Frustaci
By
Insights from 2023 ASCO® Annual Meeting
FEATURING
Anna Frustaci
32 views
June 16, 2023
Comments 0
Login to view comments.
Click here to Login
Hematology